Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin, Irinotecan, and Thalidomide in Advanced NSCLC
NCT00025285Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2001
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in non-small cell lung cancer (NSCLC), sponsored by Wake Forest University Health Sciences. Started Nov 2001; status: completed.
02
Drugs
thalidomide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00025285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025285.